Table 1. Data description of the samples (n = 30) included into the lyssavirus panel.
Lab ID | Ring trial number | Virusspecies | Genetic lineage | Year of isolation | Origin | Source | Host | R13* | R14* | R13/14* |
12952 | L-01 | RABV | NEE | 2001 | Estonia | BS | fox | 31.0 | 27.4 | 27.8 |
13091 | L-02 | RABV | Middle east | 1991 | Abu Dabi | BS | camel | 17.5 | 16.7 | 16.7 |
20280 | L-03 | RABV | Arctic-like | 2006 | Afghanistan | BS | dog | 15.7 | no Cq | 17.0 |
20295 | L-04 | RABV | Middle East | 2009 | Iraq | BS | dog | 17.4 | 12.9 | 13.4 |
13250 | L-05 | RABV | – | 1973 | Chile | BS | human | no Cq | 28.8 | 28.8 |
20293 10−1 | L-06 | RABV | Middle East | 2008 | Iraq | BS | dog | – | – | – |
NTC | L-07 | – | – | – | – | – | – | – | – | – |
13001 | L-08 | RABV | NEE | 1990 | Estonia | TCS | raccoon | 30.9 | 27.3 | 27.7 |
13136 | L-09 | RABV | Africa 2 | 1989 | Nigeria | BS | – | 22.8 | no Cq | 22.9 |
20281 | L-10 | RABV | Arctic-like | 2006 | Afghanistan | BS | dog | 14.9 | no Cq | 17.3 |
20297 | L-11 | RABV | Middle East | 2009 | Iraq | BS | horse | 14.9 | 11.9 | 11.8 |
13254 | L-12 | RABV | – | 1979 | Chile | BS | human | no Cq | 20.5 | 20.5 |
13213 | L-13 | RABV | – | 1981 | USA | TCS | skunk | 28.0 | 25.8 | 25.2 |
13044 | L-14 | RABV | Middle-East | 1990 | Saudi Arabia | TCS | fox | 20.5 | 19.4 | 19.5 |
13138 | L-15 | RABV | Africa 2 | 1989 | Nigeria | BS | dog | – | – | – |
20290 | L-16 | RABV | Middle East | 2008 | Iraq | BS | cow | 24.2 | 25.2 | 24.3 |
11164 | L-17 | RABV | CEE | 2005 | Germany | BS | fox | no Cq | 23.4 | 23.9 |
EBLV-1 | L-18 | EBLV-1 | EBLV-1a | 1968 | Germany | BS | bat | – | – | – |
20294 | L-19 | RABV | Middle East | 2008 | Iraq | BS | dog | 16.6 | 12.5 | 12.5 |
13078 | L-20 | RABV | EE | 1995 | Bulgaria | BS | human | 13.8 | 12.7 | 12.8 |
13205 | L-21 | RABV | – | 1981 | USA | BS | raccoon | – | – | – |
20291 | L-22 | RABV | Middle East | 2008 | Iraq | BS | dog | 22.6 | 18.5 | 19.1 |
SAD-B19 | L-23 | RABV | vaccine | 1991 | Germany | TCS | vaccine | 18.2 | 19.0 | 18.3 |
EBLV-2 | L-24 | EBLV-2 | EBLV-2a | 1985 | Finland | BS | human | – | – | – |
RSB50 | L-25 | – | – | – | – | – | – | – | – | – |
13081 | L-26 | RABV | – | 1985 | China | TCS | – | 26.1 | 23.0 | 22.7 |
20293_10−2 | L-27 | RABV | Middle East | 2008 | Iraq | BS | dog | – | – | – |
20293_10−3 | L-28 | RABV | Middle East | 2008 | Iraq | BS | dog | – | – | - |
13240 | L-29 | RABV | Eptesicus fuscus | 1986 | Canada | BS | bat | no Cq | 25.4 | 25.5 |
20293 | L-30 | RABV | Middle East | 2008 | Iraq | BS | dog | 16.6 | 12.6 | 13.0 |
dilution series is depicted in bold; NTC: no template control; BS: brain suspension; TCS: tissue culture supernatant; NEE: North Eastern Europe; CEE: Central and Eastern Europe; EE: Eastern Europe; RABV: Rabies virus; EBLV: European Bat Lyssavirus; –: not tested;